Impact of invasive fungal disease on outcomes in adult allogeneic hematopoietic cell transplantation: a post-hoc analysis from a nationwide Polish Adult Leukemia Group study

Abstract The present analysis is based on a retrospective cross-sectional Polish study including patients who underwent allogeneic hematopoietic cell transplantation (allo-HCT) over a 3-year period (2012–2014). The aim of the study was to evaluate the impact of the updated 2019 invasive fungal disease (IFD) diagnostic criteria on treatment outcomes and to identify risk factors for mortality. The analysis included 102 patients diagnosed with IFD for whom follow-up data were available. In accordance with the 2019 EORTC/MSGERC consensus revisions, all IFD diagnoses were re-evaluated using the available clinical data. Additionally, due to the lack of therapeutic drug monitoring (TDM), patients receiving oral posaconazole suspension who presented with multiple risk factors for IFD and radiological findings on high-resolution chest computed tomography (HRCT) suggestive of fungal infection were classified as probable IFD cases, even in the presence of negative serum galactomannan (GM) results. Using the 2008 EORTC/MSG criteria, 3-month mortality rates were comparable between patients with probable and proven IFD (47.4% and 50%, respectively) and lower among patients classified as possible IFD (27.9%). In contrast, application of the modified 2019 IFD definitions resulted in a clearer stratification of patients into possible, probable, and proven IFD categories, with distinct 3-month mortality rates of 16%, 36%, and 52.4%, respectively. In multivariate analysis, neutropenia occurring at any time after transplantation – a major risk factor for IFD development – was independently associated with increased mortality. Moreover, proven IFD diagnosed according to the updated criteria significantly increased the risk of IFD-related death. In conclusion, reclassification of IFD according to updated criteria and adjustment for historical diagnostic limitations improved prognostic stratification, yielding clinically meaningful differences in mortality among possible, probable, and proven IFD cases.

Authors

Publication Details

Journal
Annals of Hematology
Published
2026-11-16
DOI
https://doi.org/10.1007/s00277-026-07337-x
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of invasive fungal disease on outcomes in adult allogeneic hematopoietic cell transplantation: a post-hoc analysis from a nationwide Polish Adult Leukemia Group study

Jarosław Dybko, Alicja Sadowska‐Klasa, Agnieszka Piekarska, Monika Biernat et al.
Annals of Hematology
Antifungal resistance and susceptibility
article

Impact of invasive fungal disease on outcomes in adult allogeneic hematopoietic cell transplantation: a post-hoc analysis from a nationwide Polish Adult Leukemia Group study

Jarosław Dybko, Alicja Sadowska‐Klasa, Agnieszka Piekarska, Monika Biernat, Joanna Mańko, Patrycja Mensah‐Glanowska, Lidia Gil, Joanna Ewa Drozd-Sokolowska, Paulina Dumnicka, Agnieszka Tomaszewska, Piotr Stelmach, Monika Adamska
article en

Abstract

Abstract The present analysis is based on a retrospective cross-sectional Polish study including patients who underwent allogeneic hematopoietic cell transplantation (allo-HCT) over a 3-year period (2012–2014). The aim of the study was to evaluate the impact of the updated 2019 invasive fungal disease (IFD) diagnostic criteria on treatment outcomes and to identify risk factors for mortality. The analysis included 102 patients diagnosed with IFD for whom follow-up data were available. In accordance with the 2019 EORTC/MSGERC consensus revisions, all IFD diagnoses were re-evaluated using the available clinical data. Additionally, due to the lack of therapeutic drug monitoring (TDM), patients receiving oral posaconazole suspension who presented with multiple risk factors for IFD and radiological findings on high-resolution chest computed tomography (HRCT) suggestive of fungal infection were classified as probable IFD cases, even in the presence of negative serum galactomannan (GM) results. Using the 2008 EORTC/MSG criteria, 3-month mortality rates were comparable between patients with probable and proven IFD (47.4% and 50%, respectively) and lower among patients classified as possible IFD (27.9%). In contrast, application of the modified 2019 IFD definitions resulted in a clearer stratification of patients into possible, probable, and proven IFD categories, with distinct 3-month mortality rates of 16%, 36%, and 52.4%, respectively. In multivariate analysis, neutropenia occurring at any time after transplantation – a major risk factor for IFD development – was independently associated with increased mortality. Moreover, proven IFD diagnosed according to the updated criteria significantly increased the risk of IFD-related death. In conclusion, reclassification of IFD according to updated criteria and adjustment for historical diagnostic limitations improved prognostic stratification, yielding clinically meaningful differences in mortality among possible, probable, and proven IFD cases.

Annals of Hematology
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon